eResearchTechnology




		05/05/08 eResearchTechnology Reports First Quarter 2008 Results

		05/02/08 eResearchTechnology to Present at the Deutsche Bank 33rd Annual Healthcare Conference on May 7th 2008

		04/23/08 eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 2008

		04/22/08 eRT Among First To Receive CDISC Certification for New Standard

		04/14/08 eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services

		02/26/08 eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results

		02/11/08 eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008

		02/06/08 eResearchTechnology to Present at the UBS Global Healthcare Services Conference 2008 on February 11th

		01/02/08 eResearchTechnology to Present at the JPMorgan 26th Annual Healthcare Conference 2008 on January 8th

		11/27/07 eResearchTechnology (eRT) Agrees to Acquire the Centralized ECG Business of Covance

		11/01/07 eResearchTechnology Reports Third Quarter 2007 Results

		10/25/07 eResearchTechnology, Inc. to Announce 2007 Third Quarter Results on November 1, 2007

		09/20/07 eResearchTechnology to Present at the UBS Global Life Sciences Conference 2007 on September 27th




		Clinical Cardiac Safety and Data Management Solutions eRT is the leading centralized ECG core laboratory in Phase I-IV and also a leader in developing eClinical data management solutions. To Download PDF click here. A Practical Approach to Cardiac Safety By Scott Grisanti & Joel Morganroth. To Download PDF click here. Cardiac Safety Speaks to the Heart of the Critical Path Initiative By Scott Grisanti. To Download PDF click here. Clinical Labs & Trials in the 21st Century - The Thorough Phase I Trial. By Scott Grisanti. To Download PDF click here. Regulatory Affairs Professionals Society (RAPS) Posted with permission on eResearchTechnology, Inc.'s Web site (www.ert.com). Reprinted from the January 2004 issue of Regulatory Affairs Focus. To Download PDF click here. Drug-Induced Cardiac Toxicity: Emphasizing the Role of Electrocardiography in Clinical Research and Drug Development By Ihor Gussak, MD, Jeffrey Litwin, MD, Robert Kleiman, MD, Scott Grisanti, and Joel Morganroth, MD To Download PDF click here. A Definitive or Thorough Phase 1 QT ECG Trial as a Requirement for Drug Safety Assessment By Joel Morganroth, MD To Download PDF click here.

eResearchTechnology to Present at the Deutsche Bank 33rd Annual Healthcare Conference

10:10 a.m. Eastern on May 7, 2008

View Details

eResearchTechnology, Inc. Announced 2008 First Quarter Results

5:00 p.m. Eastern
May 5, 2008

View Details

ICH-E14 Two Years Later - Trends in Design & Conduct of a Thorough ECG Trial (TET)

Presented By:
Joel Morganroth M.D., F.A.C.C.
Chairman, Chief Scientist
eResearchTechnology, Inc.

View Playback

Best Practices in Cardiac Safety Data Collection Before and After the Thorough QT Trial

Presented By:
Jeffrey S. Litwin, M.D., F.A.C.C.
Executive Vice President, Chief Medical Officer
eResearchTechnology, Inc.

View Playback

eClinical Delivers Solutions

Presented By:
David J. Laky
Vice President & General Manager Clinical Data Applications
eResearchTechnology, Inc.

View Playback

Regulatory Compliance 21CFR Part11 Position Paper

Learn More